Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.
about
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeThe trials and hopes for drug development in sickle cell disease.Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.Intravascular hemolysis and the pathophysiology of sickle cell disease.
P2860
Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@ast
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@en
type
label
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@ast
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@en
prefLabel
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@ast
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@en
P2093
P2860
P1476
Anti-haemolytic effect of seni ...... ults with sickle cell anaemia.
@en
P2093
Alan T Remaley
Caterina P Minniti
Greg C Rigdon
Jonathan W Stocker
Jonathan Wilson
Laurel Mendelsohn
P2860
P304
P356
10.1111/J.1365-2141.2011.08757.X
P407
P577
2011-06-08T00:00:00Z